Showing results (101-110 of 969) with videos related to
Sort By:
Pageof 97
Expert Review of Hematology|March 3, 2023
Non-intensive acute myeloid leukemia therapies for older patientsRodrick Babakhanlou, Farhad Ravandi-KashaniClinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Acute Myeloid Leukemia: Past, Present, and Prospects for the FutureNicholas J Short, Farhad RavandiClinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemiaPaolo Strati, Naval Daver, Farhad Ravandi, et al.Clinical Lymphoma, Myeloma & Leukemia|December 1, 2022
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid LeukemiaRodrick Babakhanlou, Farhad Ravandi-KashaniExpert Review of Hematology|May 10, 2016
The safety and efficacy of vosaroxin in patients with first relapsed or refractory acute myeloid leukemia - a critical reviewNicholas J Short, Farhad RavandiSeminars in Hematology|March 22, 2006
Purine analogue combinations for indolent lymphomasNicholas Di Bella, Farhad RavandiHaematologica|July 6, 2019
How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?Nicholas J Short, Farhad RavandiFuture Oncology (London, England)|September 13, 2016
Targeting acute myeloid leukemia with TP53-independent vosaroxinChristopher B Benton, Farhad RavandiExpert Review of Hematology|July 13, 2019
Moxetumomab pasudotox for the treatment of relapsed and/or refractory hairy cell leukemiaIman Abou Dalle, Farhad RavandiPageof 97